Travere Therapeutics, INC.
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersSan Diego, CA
SAM.gov UEINot registered
Travere Therapeutics is a biopharmaceutical company focused on rare kidney disease. It develops pegtibatinase and civorebrutinib, and its work addresses IgA Nephropathy, Focal Segmental Glomerulosclerosis, Classical Homocystinuria, and Cystinuria. The company announced U.S. FDA approval related to Focal Segmental Glomerulosclerosis.
Summarized from the company’s own website
CareersCareers page — seen SEP 9, 2026
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Travere Therapeutics, INC. | San Diego | CA | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.